Spyre Therapeutics Inc. (SYRE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $43.15
• Market Cap: $3.45B
• EPS: $-1.98
• 52-Week High: $45.76
• 52-Week Low: $10.91

Market Sentiment

Spyre Therapeutics Inc. currently has a Bullish sentiment score of 0.30.

About Spyre Therapeutics Inc.

Spyre Therapeutics, Inc. is a cutting-edge biotechnology company headquartered in Waltham, Massachusetts, focused on creating transformative antibody therapeutics for inflammatory bowel disease (IBD). By employing advanced antibody engineering techniques, innovative therapeutic combinations, and precision medicine strategies, Spyre aims to effectively target and address significant unmet medical needs in the management of IBD. With a strong pipeline underscored by a commitment to personalized...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Spyre Therapeutics Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SYRE pay dividends?

Spyre Therapeutics Inc. (SYRE) does not currently pay a regular dividend.

What is SYRE's market cap?

Spyre Therapeutics Inc. (SYRE) has a market capitalization of $3.45B with a current stock price of $43.15.